[go: up one dir, main page]

HK1137186A1 - Consensus peptide - Google Patents

Consensus peptide

Info

Publication number
HK1137186A1
HK1137186A1 HK10104769.9A HK10104769A HK1137186A1 HK 1137186 A1 HK1137186 A1 HK 1137186A1 HK 10104769 A HK10104769 A HK 10104769A HK 1137186 A1 HK1137186 A1 HK 1137186A1
Authority
HK
Hong Kong
Prior art keywords
consensus peptide
biomineralization
mineralization
stimulation
induction
Prior art date
Application number
HK10104769.9A
Other languages
English (en)
Inventor
Stale Petter Lyngstadaas
Jan Eirik Ellingsen
Original Assignee
Corticalis As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corticalis As filed Critical Corticalis As
Publication of HK1137186A1 publication Critical patent/HK1137186A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/14—Peptides being immobilised on, or in, an inorganic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyamides (AREA)
  • Dental Preparations (AREA)
HK10104769.9A 2006-12-21 2010-05-14 Consensus peptide HK1137186A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87614906P 2006-12-21 2006-12-21
PCT/IB2007/004068 WO2008078167A2 (en) 2006-12-21 2007-12-21 Consensus peptide

Publications (1)

Publication Number Publication Date
HK1137186A1 true HK1137186A1 (en) 2010-07-23

Family

ID=39387381

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10104769.9A HK1137186A1 (en) 2006-12-21 2010-05-14 Consensus peptide

Country Status (13)

Country Link
US (1) US8367602B2 (xx)
EP (1) EP2118136B1 (xx)
JP (1) JP5253412B2 (xx)
KR (2) KR20150014999A (xx)
AT (1) ATE475670T1 (xx)
AU (1) AU2007337797B2 (xx)
CA (1) CA2673382C (xx)
DE (1) DE602007008147D1 (xx)
DK (1) DK2118136T3 (xx)
ES (1) ES2349889T3 (xx)
HK (1) HK1137186A1 (xx)
PL (1) PL2118136T3 (xx)
WO (1) WO2008078167A2 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011111832A1 (ja) * 2010-03-11 2011-09-15 独立行政法人理化学研究所 ポリペプチド配列の選択方法、並びに金属酸化物または含珪素化合物結合ペプチドおよびその利用
SE537635C2 (sv) 2012-09-18 2015-08-25 Corticalis As Metod för att producera en alginatbelagd titandioxidscaffold, denna titandioxidscaffold samt medicinskt implantatinnefattande scaffolden
WO2021191903A1 (en) * 2020-03-26 2021-09-30 Bone Sci. Bio Ltd. Pharmaceutical compositions comprising amphiphilic peptides and methods of use thereof
WO2025012149A1 (en) * 2023-07-07 2025-01-16 Nupep As Consensus peptides in hya
EP4487834A1 (en) * 2023-07-07 2025-01-08 NuPep AS Consensus peptides in hya
EP4487863A1 (en) * 2023-07-07 2025-01-08 NuPep AS Consensus peptides in hya for use in treating degenerated joints

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786327A (en) 1993-03-12 1998-07-28 Gensci Regeneration Sciences Inc. Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same
IL108947A0 (en) * 1993-03-12 1994-06-24 Osteopharm Ltd Bone stimulating factor
US7132015B2 (en) * 2002-02-20 2006-11-07 University Of Southern California Materials for dental and biomedical application
EP2329832A1 (en) * 2004-12-10 2011-06-08 Straumann Holding AG Protein formulation
US8796417B2 (en) 2005-05-27 2014-08-05 Japan Science And Technology Agency Three-dimensional structure of functional material

Also Published As

Publication number Publication date
US20100172949A1 (en) 2010-07-08
EP2118136A2 (en) 2009-11-18
DE602007008147D1 (de) 2010-09-09
US8367602B2 (en) 2013-02-05
PL2118136T3 (pl) 2011-04-29
JP5253412B2 (ja) 2013-07-31
DK2118136T3 (da) 2010-11-15
JP2010513460A (ja) 2010-04-30
AU2007337797B2 (en) 2012-08-23
WO2008078167A2 (en) 2008-07-03
KR20150014999A (ko) 2015-02-09
WO2008078167A3 (en) 2008-08-21
EP2118136B1 (en) 2010-07-28
AU2007337797A1 (en) 2008-07-03
KR101493437B1 (ko) 2015-02-16
ES2349889T3 (es) 2011-01-12
CA2673382A1 (en) 2008-07-03
CA2673382C (en) 2016-03-29
ATE475670T1 (de) 2010-08-15
KR20090117702A (ko) 2009-11-12

Similar Documents

Publication Publication Date Title
MY158325A (en) Multitype peptide compositions and methods for treatment or prevention of human papillpmavirus infection
UA106399C2 (xx) Аналог оксинтомодуліну[аналог оксинтомодулина
TN2012000302A1 (en) Oxyntomodulin peptide analogue
MX357801B (es) Agentes dirigidos a gadd45beta.
MX2009006466A (es) Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina.
NZ593474A (en) Compositions and methods for treatment of celiac disease
LT2506857T (lt) Mrnr tiekimas baltymų ir fermentų papildymui žmogaus genetinių ligų atvejais
HK1137186A1 (en) Consensus peptide
MX2019011592A (es) Peptidos y analogos de peptidos protectores de los tejidos para evitar y tratar padecimientos y desordenes asociados con daño de los tejidos.
ZA200702322B (en) Compositions and methods for the diagnosis and treatment of tumor
MX2012009748A (es) USO DE PEPTIDOS INHIBIDORES DEL FACTOR DE CRECIMIENTO TRANSFORMANTE-BETA1(TGF-ß1) PARA EL TRATAMIENTO DE FIBROSIS Y/U OPACIDAD CORNEAL.
ZA200900379B (en) Human endogenous retrovirus polypeptide compositions and methods of use thereof
IL210810B (en) Peptides to treat pain and/or inflammation
MX2012001346A (es) Polipeptidos del factor ix modificados y usos de los mismos.
PH12012502406A1 (en) Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies
WO2007111661A3 (en) Human antibodies specific for gastrin materials and methods
EP2166845A4 (en) ALPHA CONNEXIN C TERMINAL (ACT) PEPTIDES FOR THE TREATMENT OF AGE-RELATED MACULAR AGENCY
HK1127910A1 (en) Compositions containing peptides with non-natural amino acids and methods of use
TN2009000135A1 (en) Use of modified cyclosporins
EP2294197A4 (en) HHIP1 PROTEIN VERSION AND METHOD AND USES THEREOF
EP2552462A4 (en) CCN3 THERAPEUTIC PEPTIDES AND THEIR ANALOGS
MX2009005550A (es) Inhibidores de fosfatasa de proteina tirosina para la promocion de la hipertrofia cardiaca fisiologica.
MX2010005280A (es) Nuevos peptidos sinteticos sustituidos con arginina y su uso.
MX2008001183A (es) Peptidil diacilgliceridos.
GB201018125D0 (en) Peptide